Mai A Abd El Fattah
Overview
Explore the profile of Mai A Abd El Fattah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muhammad R, Albahairy M, Abd El Fattah M, Ibrahim W
Psychopharmacology (Berl)
. 2024 Aug;
241(12):2565-2584.
PMID: 39158617
Rationale: Major depression has been an area of extensive research during the last decades, for it represents a leading cause of disability and suicide. The stark rise of depression rates...
2.
Samra A, Kamel A, Abdallah D, Abd El Fattah M, Ahmed K, El-Abhar H
Biomedicines
. 2023 Dec;
11(12).
PMID: 38137376
Autism spectrum disorder (ASD) prevalence is emerging with an unclear etiology, hindering effective therapeutic interventions. Recent studies suggest potential renin-angiotensin system (RAS) alterations in different neurological pathologies. However, its implications...
3.
El-Latif A, Rabie M, Sayed R, Abd El Fattah M, Kenawy S
Drug Dev Res
. 2023 May;
84(6):1159-1174.
PMID: 37170799
Growing evidence points to impaired autophagy as one of the major factors implicated in the pathophysiology of Parkinson's disease (PD). Autophagy is a downstream target of adenosine monophosphate-activated protein kinase...
4.
Shibrya E, Rashed R, Abd El Fattah M, El-Ghazaly M, Kenawy S
Dose Response
. 2023 Feb;
21(1):15593258231155787.
PMID: 36756150
Ulcerative colitis (UC) is an inflammatory bowel disease involving chronic and recurring colon inflammation. Current management protocols are limited by adverse effects or short-term symptomatic relief. We aimed to investigate...
5.
Mohamed Y, Salama A, Rabie M, Abd El Fattah M
Int Immunopharmacol
. 2022 Dec;
114:109571.
PMID: 36527875
Neuroinflammatory status produced via activation of toll like receptor-4 (TLR-4) and interleukin-17 receptor (IL-17R) is one of the principal mechanisms involved in dopaminergic neuronal loss in Parkinson's disease (PD). Activation...
6.
Gamil N, Abd El Fattah M, Ahmed M, Maklad Y, Gamal El Din A, Eid N
J Biochem Mol Toxicol
. 2020 Jan;
34(4):e22451.
PMID: 31975531
Dapagliflozin (DAPA) is used for treating type 2 diabetes, whereas lansoprazole (LPZ) is used as a traditional antiulcer drug. The present study investigated the possible antidiabetic effects of LPZ on...
7.
Rabie M, Abd El Fattah M, Nassar N, Abdallah D, El-Abhar H
Biochem Pharmacol
. 2019 Nov;
171:113681.
PMID: 31669235
In the current investigation, a Parkinson's disease (PD) model was established by a single direct right intrastriatal injection of the 6-hydroxydopamine (OHDA) in male Wistar rats followed by 7 daily...
8.
Aziz M, Abd El Fattah M, Ahmed K, Sayed H
Can J Physiol Pharmacol
. 2019 Oct;
98(4):183-193.
PMID: 31665614
Doxorubicin (DOX), an anthracycline antibiotic, is an important antineoplastic agent due to its high antitumor efficacy in hematological as well as in solid malignancies. The clinical use of DOX is...
9.
Kamel N, Abd El Fattah M, El-Abhar H, Abdallah D
Eur J Pharmacol
. 2019 Aug;
861:172620.
PMID: 31437429
The reno-protective effects of antidiabetic dipeptidyl peptidase (DPP)-4 inhibitors have been studied regarding their antioxidant and anti-inflammatory properties. However, the potential ability of saxagliptin to ameliorate renal injury by enhancing...
10.
Kandil E, Sayed R, Ahmed L, Abd El Fattah M, El-Sayeh B
Clin Exp Pharmacol Physiol
. 2019 Aug;
46(12):1141-1150.
PMID: 31408200
Hypoxia-inducible factor-1 alpha (HIF-1α) and nuclear receptor related-1 (Nurr1) play pivotal roles in the development and survival of dopaminergic neurons, and deficiencies in these genes may be involved in Parkinson's...